[1]韩林峰,柯根杰,顾永昊,等.甲强龙联合地塞米松交替球周注射治疗脉络膜脱离型视网膜脱离[J].眼科新进展,2015,35(10):935-938.[doi:10.13389/j.cnki.rao.2015.0255]
　HAN Lin-Feng,KE Gen-Jie,GU Yong-Hao,et al.Alternating peribulbar injection of methylprednisolone and dexamethasone for combined choroidal detachment and retinal detachment[J].Recent Advances in Ophthalmology,2015,35(10):935-938.[doi:10.13389/j.cnki.rao.2015.0255]
点击复制

甲强龙联合地塞米松交替球周注射治疗脉络膜脱离型视网膜脱离
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
35卷
期数:
2015年10期
页码:
935-938
栏目:
应用研究
出版日期:
2015-10-05

文章信息/Info

Title:
Alternating peribulbar injection of methylprednisolone and dexamethasone for combined choroidal detachment and retinal detachment
作者:
韩林峰; 柯根杰; 顾永昊; 董凯
230001　安徽省合肥市，安徽医科大学附属省立医院眼科
Author(s):
HAN Lin-Feng ;  KE Gen-Jie ;  GU Yong-Hao ; DONG Kai
Department of Ophthalmology , Anhui Provincial Hospital , Anhui Medical University , Hefei 230001 , Anhui Province . China
关键词:
糖皮质激素; 球周注射; 脉络膜脱离型视网膜脱离; 眼压; 最佳矫正视力
Keywords:
glucocorticoid;  peribulbar injection;  choroidal detachment and retinal detachment ;  intraocular pressure ;  best corrected visual acuity
DOI:
10.13389/j.cnki.rao.2015.0255
文献标志码:
A
摘要:
目的　评价甲强龙联合地塞米松交替球周注射在玻璃体切割术治疗脉络膜脱离型视网膜脱离中的疗效。方法　回顾性分析我科２０１２年１月至２０１３年１２月收治的临床确诊为脉络膜脱离型视网膜脱离的患者共４６例４６眼。按糖皮质激素的给药途径，分为静脉组与球周组各２３例２３眼，均行玻璃体切除＋硅油充填术，术后随访１２个月以上。对比两组手术前后最佳矫正视力、眼压、术前糖皮质激素使用时间、不良反应发生率、视网膜脱离一次手术复位率、视网膜脱离复发率等。结果　静脉组与球周组患者入院时眼压分别为（６．７４±２．３３）ｍｍＨｇ（１ｋＰａ＝７．５ｍｍＨｇ）和（６．９６±１．８８）ｍｍＨｇ，使用糖皮质激素后术前眼压分别为（９．３４±１．５０）ｍｍＨｇ和（９．４３±１．０８）ｍｍＨｇ；最佳矫正视力入院时分别为２．０７±０．１４和２．２３±０．１６，出院时分别为２．０２±０．１７和２．０３±０．１４，两组组内比较差异均有统计学意义（均为Ｐ＜０．０５），而组间比较差异均无统计学意义（均为Ｐ＞０．０５）。术后１２个月内静脉组与球周组一次性视网膜脱离复位例数分别为１９例和２１例、视网膜脱离复发例数分别为４例和２例，差异均无统计学意义（均为Ｐ＞０．０５）；而两组在术前糖皮质激素使用时间，静脉组为（５．３５±０．１２）ｄ、球周组为（４．０４±０．３８）ｄ，差异有统计学意义（ｔ＝２．３１，Ｐ＝０．０３）；糖皮质激素使用不良反应，静脉组为６例、球周组为０例，差异有统计学意义（χ２＝６．９，Ｐ＝０．００９）。结论　甲强龙联合地塞米松交替球周注射是一种玻璃体切割术治疗脉络膜脱离型视网膜脱离的安全有效的方法。
Abstract:
Objective To evaluate curative effects of alternating peribulbar injection of methylprednisolone and dexamethasone in vitrectomy for choriodal detachment and retinal detachment. Methods Retrospective analysis was performed on 46 cases (46 eyes) of patients who were definitely diagnosed as choriodal detachment and retinal detachment . and accepted treatment in our department from January 2012 to December 2013. The patients were divided into two groups , namely vein group and peribulbar group according to administration route of glucocorticoid.23 cases in each group. The vitrectomy and silicone oil filling operation was applied for both groups and follow-up treatment was performed for more than six months. The preoperative and postoperative best corrected visual acuity , intraocular pressure variation, preoperative glucocorticoid applying time.occurrence rate of adverse reaction.one-time surgical reduction rate of retinal detachment, recurrence of retinal detachment were analyzed in the two groups. Results The intraocular pressure in vein group and peribulbar group at being admitted to hospital were ( 6. 74 +2. 33) mmHg ( I kPa = 7. 5 mmHg) and ( 6. 96 + 1. 88 ) mmHg , respectively, the preoperative intraocular pressure after applying glucocorticoid were ( 9. 34 + 1. 50) mmHg and ( 9. 43 + 1. 08 ) mmHg , respectively ; The best corrected visual acuity at being admitted to hospital were 2. 07 + 0. 14 and 2. 23 + 0. 16 , respectively , and were 2. 02 + 0. 17 and l. 03 + 0. 14 when discharged from the hospital, there were statistical differences between intra-groups(P < 0. 05 ) ,while the difference among groups was not statistically sigruficant(P > 0. 05 ) . The one-time retinal detachment reduction cases of vein group and peribulbar group within 12 months were 19 and 21 , respectively. The reduction cases of retinal detachment were 4 and 2 , respectively. The difference was not statistically significant(P > 0. 05 ) . The applying time of preoperative glucocorticoid in the vein group and peribulbar group were ( 5. 35 + 0. 12 ) days and ( 4. 04 + 0. 38 ) days ( t = 2. 31 ,P = 0. 03 ) . The adverse reaction of glucocorticoid application in the vein group and peribulbar group were 6 cases and o case(X2 = 6. 9 ,P = 0. 009) . Conclusion Alternating peribulbar injection of methylprednisolone and dexamethasone is a safe and effective therapy method in vitrectomy for choriodal detachment and retinal detachment.

相似文献/References:

[1]谭业双 周霞 许 玲 王玲丽 樊玲.抗炎治疗睑板腺功能障碍的临床研究[J].眼科新进展,2012,32(1):000.
[2]赵勇 张卯年 任兵.激素缓释系统治疗糖尿病黄斑水肿新进展[J].眼科新进展,2012,32(10):000.
[3]冯雪莲 李宗美.小柳原田综合征激素治疗致双侧股骨头坏死1例[J].眼科新进展,2009,29(1):000.
[4]赵莲,陈建卓,王红霞. 眼眶炎性假瘤的临床病理特征分析及治疗效果观察[J].眼科新进展,2015,35(8):759.[doi:10.13389/j.cnki.rao.2015.0208]
　ZHAO Lian,CHEN Jian-Zhuo,WANG Hong-Xia. Clinical pathologic analysis and therapeutic effects of orbital inflammatory pseudotumor[J].Recent Advances in Ophthalmology,2015,35(10):759.[doi:10.13389/j.cnki.rao.2015.0208]
[5]杨洪波,杨向红. 葡萄膜炎并发白内障手术治疗的临床观察[J].眼科新进展,2015,35(9):873.[doi:10.13389/j.cnki.rao.2015.0238]
　YANG Hong-Bo,YANG Xiang-Hong. Clinical observation of surgical treatment for uveitis complicated with cataract[J].Recent Advances in Ophthalmology,2015,35(10):873.[doi:10.13389/j.cnki.rao.2015.0238]
[6]张振瑜,吴京,马明,等.纤维介素蛋白2（FGL-2）在大鼠角膜移植排斥反应中的作用[J].眼科新进展,2015,35(10):913.[doi:10.13389/j.cnki.rao.2015.0249]
　ZHANG Zhen-Yu,WU Jing,MA Ming,et al.Role of FGL-2 in corneal graft rejection after allograft transplantation in rats[J].Recent Advances in Ophthalmology,2015,35(10):913.[doi:10.13389/j.cnki.rao.2015.0249]
[7]杜君,雷方.Vogt-小柳-原田综合征黄斑中心凹脉络膜厚度分析[J].眼科新进展,2016,36(8):777.[doi:10.13389/j.cnki.rao.2016.0208]
　DU Jun,LEI Fang.Subfoveal choroidal thickness in eyes with Vogt-Koyanagi-Harada disease[J].Recent Advances in Ophthalmology,2016,36(10):777.[doi:10.13389/j.cnki.rao.2016.0208]
[8]路迎龙,杜倩,李筱荣,等.葡萄膜炎继发黄斑囊样水肿的临床研究[J].眼科新进展,2017,37(2):147.[doi:10.13389/j.cnki.rao.2017.0039]
　LU Ying-Long,DU Qian,LI Xiao-Rong,et al.Efficacy of uveitis secondary to cystoid macular edema[J].Recent Advances in Ophthalmology,2017,37(10):147.[doi:10.13389/j.cnki.rao.2017.0039]
[9]朱婷婷,王权,姜彩辉.糖尿病黄斑水肿治疗新进展[J].眼科新进展,2019,39(3):296.[doi:10.13389/j.cnki.rao.2019.0067]
　ZHU Ting-Ting,WANG Quan,JIANG Cai-Hui.Recent research advances in the treatment of diabetic macular edema[J].Recent Advances in Ophthalmology,2019,39(10):296.[doi:10.13389/j.cnki.rao.2019.0067]
[10]高瑞莹,李仕永,陈晖,等.玻璃体内注射雷珠单抗联合糖皮质激素治疗Ⅱ型视盘血管炎继发黄斑水肿的疗效观察[J].眼科新进展,2019,39(5):469.[doi:10.13389/j.cnki.rao.2019.0108]
　GAO Rui-Ying,LI Shi-Yong,CHEN Hui,et al.Observation of intravitreal Ranibizumab injection combined with glucocorticoid in treatment for macular edema secondary to type Ⅱ optic disc vasculitis[J].Recent Advances in Ophthalmology,2019,39(10):469.[doi:10.13389/j.cnki.rao.2019.0108]

备注/Memo

备注/Memo:
安徽省自然科学基金青年项目（编号：１４０８０８５ＱＨ１５９）
更新日期/Last Update: 2015-09-30